The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer

Gynecologic Oncology

Volumn 132, Issue 3, 2014, Pages 730-738

  Sun, Qingmin ^a,b   Zou, Xi ^a   Zhang, Ting ^b   Shen, Jian ^a   Yin, Yongxiang ^b   Xiang, Jingying ^b  

^a AFFILIATED HOSPITAL OF NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

EphA2; miR 200a; Ovarian cancer; Vasculogenic mimicry

Indexed keywords

EPHRIN RECEPTOR A2; MICRORNA 200A;

ADULT; ARTICLE; BIOINFORMATICS; CANCER GRADING; CANCER PATIENT; CANCER STAGING; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUCIFERASE ASSAY; MAJOR CLINICAL STUDY; METASTASIS; MIDDLE AGED; MOLECULAR MIMICRY; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULOGENIC MIMICRY; WESTERN BLOTTING;

EPHA2; MIR-200A; OVARIAN CANCER; VASCULOGENIC MIMICRY;

3' UNTRANSLATED REGIONS; ANTIGENS, CD34; CELL LINE, TUMOR; DOWN-REGULATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; OVARIAN NEOPLASMS; RECEPTOR, EPHA2; TRANSFECTION;

EID: 84896396426     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.01.047     Document Type: Article

References (38)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. A.J. Maniotis, R. Folberg, A. Hess, E.A. Seftor, L.M. Gardner, and J. Pe'er et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry Am J Pathol 155 1999 739 752
3. D.A. Kirschmann, E.A. Seftor, K.M. Hardy, R.E. Seftor, and M.J. Hendrix Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications Clin Cancer Res 18 2012 2726 2732
4. R.E. Seftor, A.R. Hess, E.A. Seftor, D.A. Kirschmann, K.M. Hardy, and N.V. Margaryan et al. Tumor cell vasculogenic mimicry: from controversy to therapeutic promise Am J Pathol 181 2012 1115 1125
5. R. Cong, Q. Sun, L. Yang, H. Gu, Y. Zeng, and B. Wang Effect of genistein on vasculogenic mimicry formation by human uveal melanoma cells J Exp Clin Cancer Res 28 2009 124
6. S. Wu, L. Yu, D. Wang, L. Zhou, Z. Cheng, and D. Chai et al. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry BMC Cancer 12 2012 535
7. R. Liu, K. Yang, C. Meng, Z. Zhang, and Y. Xu Vasculogenic mimicry is a marker of poor prognosis in prostate cancer Cancer Biol Ther 13 2012 527 533
8. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2004 281 297
9. A. Esquela-Kerscher, and F.J. Slack Oncomirs - microRNAs with a role in cancer Nat Rev Cancer 6 2006 259 269
10. Y.W. Chung, H.S. Bae, J.Y. Song, J.K. Lee, N.W. Lee, and T. Kim et al. Detection of microRNA as novel biomarkers of epithelial ovarian cancer from the serum of ovarian cancer patient Int J Gynecol Cancer 23 2013 673 679
11. L. Xu, J. Xiang, J. Shen, X. Zou, S. Zhai, and Y. Yin et al. Oncogenic MicroRNA-27a is a target for genistein in ovarian cancer cells Anticancer Agents Med Chem 13 2013 1126 1132
12. M.V. Iorio, R. Visone, G. Di Leva, V. Donati, F. Petrocca, and P. Casalini et al. MicroRNA signatures in human ovarian cancer Cancer Res 67 2007 8699 8707
13. A. Chao, C.Y. Lin, Y.S. Lee, C.L. Tsai, P.C. Wei, and S. Hsueh et al. Regulation of ovarian cancer progression by microRNA-187 through targeting disabled homolog-2 Oncogene 31 2012 764 775
14. E. Aydogdu, A. Katchy, E. Tsouko, C.Y. Lin, L.A. Haldosen, and L. Helguero et al. MicroRNA-regulated gene networks during mammary cell differentiation are associated with breast cancer Carcinogenesis 33 2012 1502 1511
15. J. Walker-Daniels, A.R. Hess, M.J. Hendrix, and M.S. Kinch Differential regulation of EphA2 in normal and malignant cells Am J Pathol 162 2003 1037 1042
16. N. Cheng, D.M. Brantley, H. Liu, Q. Lin, M. Enriquez, and N. Gale et al. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis Mol Cancer Res 1 2002 2 11
17. D.M. Brantley-Sieders, W.B. Fang, D.J. Hicks, G. Zhuang, Y. Shyr, and J. Chen Impaired tumor microenvironment in EphA2-deficient mice inhibits tumor angiogenesis and metastatic progression FASEB J 19 2005 1884 1886
18. T. Ojima, H. Takagi, K. Suzuma, H. Oh, I. Suzuma, and H. Ohashi et al. EphrinA1 inhibits vascular endothelial growth factor-induced intracellular signaling and suppresses retinal neovascularization and blood-retinal barrier breakdown Am J Pathol 168 2006 331 339
19. C.N. Landen, M.S. Kinch, and A.K. Sood EphA2 as a target for ovarian cancer therapy Expert Opin Ther Targets 9 2005 1179 1187
20. O. Itzhaki, E. Greenberg, B. Shalmon, A. Kubi, A.J. Treves, and R. Shapira-Frommer et al. Nicotinamide inhibits vasculogenic mimicry, an alternative vascularization pathway observed in highly aggressive melanoma PLoS One 8 2013 e57160
21. B. Sun, S. Zhang, D. Zhang, J. Du, H. Guo, and X. Zhao et al. Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma Oncol Rep 16 2006 693 698
22. M. Su, Y.J. Feng, L.Q. Yao, M.J. Cheng, C.J. Xu, and Y. Huang et al. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo Int J Gynecol Cancer 18 2008 476 486
23. X.M. Liu, Q.P. Zhang, Y.G. Mu, X.H. Zhang, K. Sai, and J.C. Pang et al. Clinical significance of vasculogenic mimicry in human gliomas J Neurooncol 105 2011 173 179
24. C.I. Baeten, F. Hillen, P. Pauwels, A.P. de Bruine, and C.G. Baeten Prognostic role of vasculogenic mimicry in colorectal cancer Dis Colon Rectum 52 2009 2028 2035
25. Y. Gao, X.L. Zhao, Q. Gu, J.Y. Wang, S.W. Zhang, and D.F. Zhang et al. Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma Zhonghua Bing Li Xue Za Zhi 38 2009 585 589
26. X. Yao, Y. Ping, Y. Liu, K. Chen, T. Yoshimura, and M. Liu et al. Vascular endothelial growth factor receptor 2 (VEGFR-2) plays a key role in vasculogenic mimicry formation, neovascularization and tumor initiation by glioma stem-like cells PLoS One 8 2013 e57188
27. Q. Wu, R. Guo, M. Lin, B. Zhou, and Y. Wang MicroRNA-200a inhibits CD133/1 + ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2 Gynecol Oncol 122 2011 149 154
28. X. Hu, D.M. Macdonald, P.C. Huettner, Z. Feng, I.M. El Naqa, and J.K. Schwarz et al. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer Gynecol Oncol 114 2009 457 464
29. G. Eades, M. Yang, Y. Yao, Y. Zhang, and Q. Zhou miR-200a regulates Nrf2 activation by targeting Keap1 mRNA in breast cancer cells J Biol Chem 286 2011 40725 40733
30. N. Cong, P. Du, A. Zhang, F. Shen, J. Su, and P. Pu et al. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/beta-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma Oncol Rep 29 2013 1579 1587
31. S.J. Yu, J.Y. Hu, X.Y. Kuang, J.M. Luo, Y.F. Hou, and G.H. Di et al. MicroRNA-200a promotes anoikis resistance and metastasis by targeting YAP1 in human breast cancer Clin Cancer Res 19 2013 1389 1399
32. A.R. Hess, E.A. Seftor, L.M. Gruman, M.S. Kinch, R.E. Seftor, and M.J. Hendrix VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry Cancer Biol Ther 5 2006 228 233
33. N. Wu, X. Zhao, M. Liu, H. Liu, W. Yao, and Y. Zhang et al. Role of microRNA-26b in glioma development and its mediated regulation on EphA2 PLoS One 6 2011 e16264
34. C. Lu, M.M. Shahzad, H. Wang, C.N. Landen, S.W. Kim, and J. Allen et al. EphA2 overexpression promotes ovarian cancer growth Cancer Biol Ther 7 2008 1098 1103
35. Y.G. Lin, L.Y. Han, A.A. Kamat, W.M. Merritt, C.N. Landen, and M.T. Deavers et al. EphA2 overexpression is associated with angiogenesis in ovarian cancer Cancer 109 2007 332 340
36. P.H. Thaker, M. Deavers, J. Celestino, A. Thornton, M.S. Fletcher, and C.N. Landen et al. EphA2 expression is associated with aggressive features in ovarian carcinoma Clin Cancer Res 10 2004 5145 5150
37. W.M. Merritt, P.H. Thaker, C.N. Landen Jr., M.T. Deavers, M.S. Fletcher, and Y.G. Lin et al. Analysis of EphA2 expression and mutant p53 in ovarian carcinoma Cancer Biol Ther 5 2006 1357 1360
38. W.M. Merritt, A.A. Kamat, J.Y. Hwang, J. Bottsford-Miller, C. Lu, and Y.G. Lin et al. Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer Cancer Biol Ther 10 2010 1306 1314